The Lure of the FDA Q-Sub Meeting: When (and When Not) to Call for One – Part 1
The Lure of the FDA Q-Sub Meeting: When (and When Not) to Call for One Part 1: Timing considerations Jim Kasic, CEO & Chairman, Boulder iQ Ah. The Q-Sub. The FDA loves Q-Sub meetings, manufacturers love to get FDA input and they’re free. What’s the issue? There is no issue – when product developers use […]